Background. Polypharmacy is known to increase the risk for drug-related problems, and some drugs, potentially inappropriate medications (PIMs), are especially troublesome. Objective. To analyse the effects on prescription of PIMs of the SÄKLÄK project, an intervention model created to improve medication safety for elderly patients in primary care. Method. The SÄKLÄK project was a multiprofessional intervention in primary care consisting of self-assessment, peer review, feedback and written agreements for change. Five Swedish primary care centres participated in the intervention and five served as comparison group. Data were collected from the Swedish Prescribed Drug Register on PIMs (long-acting benzodiazepines, anticholinergics, tramadol, propiomazine, antipsychotics and non-steroidal anti-inflammatory drugs) prescribed to patients aged 65 years and older. Total number of patients and change in patients using PIMs before and after intervention with-in groups was analysed as well as differences between intervention and comparison group. Results. A total of 32 566 prescriptions of PIMs were dispensed before the intervention, 19 796 in the intervention group and 12 770 in the comparison group. After intervention a decrease was seen in both groups, intervention-22.2% and comparison-8.8%. All groups of PIMs decreased, except for antipsychotics in the comparison group. For the intervention group, a significant decrease in mean dose/patient was seen after the intervention but not in the comparison group. Conclusion. Our study shows this method has some effects on prescription of PIMs. The evaluation indicates this is a feasible method for improvement of medication use in primary care and the method should be tested on a larger scale.
Introduction
Worldwide, the elderly population is increasing, and demographic data estimate that 22% of the global population will be older than 65 years by 2050 (1) . Ageing is known to be associated with an increased prevalence of multiple chronic diseases and thereby the use of an increased number of medications. Elderly patients with multiple diseases and polypharmacy risk suffering from drug-related problems (DRPs). Some drugs, such as potentially inappropriate medications (PIMs), are especially troublesome. These can be defined as medications for which the risks outweigh the benefits for elderly patients (2) . Different criteria for classifying inappropriate prescriptions have been proposed. The Medication Appropriateness Index (MAI) (3) is an instrument used to determine a drug's suitability to an individual, which has been validated for evaluating drug use in the elderly (4). Beer's criteria (5) list medications to be avoided in elderly patients. However, since many of these medications are unavailable in Europe, criteria corresponding to European drug formularies have been developed, such as the EU (7)-PIM list (6) and the Swedish quality indicators developed by the Swedish National Board of Health and Welfare (2) .
The use of PIMs, defined according to the Swedish quality indicators, has decreased in Sweden between 2005 and 2014. The decrease could be explained by focused efforts by the Swedish county councils and a national improvement strategy (7) . It should however be noted that 8.1% of the population aged 75 years or older still used PIMs in 2014 (8) . Furthermore, according to a Swedish study, 26.4% of elderly adults in nursing homes used at least one PIM (9) . Other international studies report different figures, depending on classification of PIMs, type of living (own home or nursing homes) and country for example (10, 11) .
The present pilot study analysed effects of the SÄKLÄK project, an intervention model created to improve medication safety for elderly patients in primary care, on the prescription of PIMs. The intervention model was originally developed for, and successfully implemented in, Swedish hospital care, to improve patient safety (12, 13) . The intervention was adapted to primary care by the six participating professional organizations and consists of self-assessment followed by peer review, feedback and a written agreement for change. The participants' experiences of the method and an analysis of identified improvement needs and agreements for changes have already been studied (14) .
The aim of this study was to assess the effect of the SÄKLÄK project on prescription of PIMs in elderly primary care patients.
Method

Setting
Ten Swedish primary care centres participated in the SÄKLÄK pilot project. Participation was open to all primary care units in Sweden (~1200). Information about the study was presented at the Swedish College of General Practice yearly congress, in some regional information materials, as well as by email to managers at primary care centres. Despite a short application timeline and no reimbursement for participation, a total of 20 units applied, and they were stratified according to urban (12 units) or rural location (8 units) . Within these groups, there were no major differences. We therefore randomized among all 12 units and all 8 units, respectively. Using Excel, five units were randomized to the intervention group and five to the comparison group, keeping the distribution between urban and rural units. The participating primary care centres varied in size between 2400 and 13 700 patients. The intervention took place between September 2013 and May 2014, with follow-up in October 2014.
Intervention model (SÄKLÄK project)
The overall aim of the SÄKLÄK project was to reduce medication errors and DRPs.
The SÄKLÄK project was initiated by the Swedish Association of Local Authorities and Regions (SALAR) and the Patient Insurance LÖF. This was a pilot study of the SÄKLÄK project to determine whether an intervention model, developed in hospital care, could be used in primary care to enhance medication safety for elderly patients.
The intervention consisted of several steps. The first step was a self-assessment questionnaire, to be answered by the primary care centres together with pharmacies, hospitals and municipally provided home care. It consisted of questions regarding how patient safety is maintained during prescription of medication, medication use and follow-up, and specifically frail elderly patients at the primary care centre. The focus of the questions was on how the primary care centres currently handle medication reviews, cooperation with pharmacies and secondary care, and, not least, how to ensure these measures are followed. In the second step of the intervention, a group of selected doctors, nurses and pharmacists, with vast experience in elderly care, served as reviewers. With support from the project management team and written instructions and documents, the reviewers analysed the self-assessment questionnaires and any additional material supplied by the primary care units. They had opportunity to get clarifications regarding any questions during site visits. Thereafter, the reviewers produced a written feedback report for the primary care unit and, together with the management at the primary care unit, agreed on an action plan for improvements. The improvement plan was followed-up after 6 months.
For further details, please see previously published article (14) .
Potentially inappropriate medications
The project selected and analysed six drug-specific quality indicators, in accordance with the indicators described by the Swedish National Board of Health and Welfare (2). These included 'anticholinergic drugs', 'long-acting benzodiazepines', 'tramadol', 'propiomazine', 'antipsychotic drugs' and 'non-steroidal anti-inflammatory drug (NSAID)' (Table 1) . According to the quality indicators, the use of 'anticholinergic drugs', 'long-acting benzodiazepines', 'tramadol' and 'propiomazine' should be as low as possible, regardless of indication, for older patients. For 'antipsychotic drugs' and 'NSAID', it is of particular importance to ensure correct and current indication. However, as the indication was not captured by the dispensing database in the present study and side effects of these drugs are common, antipsychotic drugs and NSAID were also classified by the same quality indicator, i.e. for the dose to be as low as possible, regardless of indication. Morphine-scopolamine and glycopyrrolate were excluded from the analysis (mainly palliative use).
Data collection
Data were collected from the Swedish Prescribed Drug Register (15) that includes all drugs dispensed at Swedish community pharmacies since 2005. The register is managed by the National Board of Health and Welfare and includes data for individual patients on substance, brand name, formulation, package and date of prescription and dispensing. All drugs are classified according to the Anatomical Therapeutic Chemical (ATC) Classification System. Multi-dose drug dispensing, i.e. all drugs that are to be ingested at the same time are machine dispensed in unit bags, is included in the register. The system with multi-dose drug dispensing is very common in nursing homes in Sweden. All other prescriptions were defined as ordinary prescriptions. Drugs used in hospitals and over-the-counter (OTC) drugs are not included. Dispensed drugs were used here as a proxy for prescribed drugs in this study, since data only are available for dispensed drugs.
Information about all dispensed prescriptions for patients aged 65 years and older from the participating primary care centres (five intervention and five comparison) was collected from the registry for: antipsychotics, drugs with anticholinergic effects, long-acting benzodiazepines, tramadol, propiomazine and NSAIDs (see Table 1 ). These data were collected for two periods, 12 months before (June 2012-May 2013) and 12 months after (June 2014-May 2015) the intervention.
Data analysis
Comparisons between age groups (65-79 years and 80+) and gender were performed.
Total number of patients and change in number of patients using PIMs before and after the intervention were analysed as well as differences in the change between the intervention and the control group. Total number of prescriptions of PIMs and mean number of prescriptions per patient were also presented. Mean defined daily dose (DDD) per patient (combined for all PIMs) were analysed in the same way as well as differences between ordinary prescriptions and multi-dose drug dispensing.
Data were analysed using IBM SPSS version 22. Hypothesis testing using 95% confidence interval for the mean difference was used to compare groups before and after intervention. Hypothesis testing using chi-square test was used to compare percentages of different PIM groups for ordinary prescriptions and multi-dose dispensing. Other hypothesis testing was not possible due to the data set containing a mix of dependent and independent observations. A significance level (α) of 0.05 was used.
Results
At baseline, almost 68% of the prescriptions were dispensed to patients in the age category 65-79 years and 63% to women. The vast majority (84.7%) of the patients had ordinary prescriptions, 13.8% had multi-dose drug dispensing and 1.5% had both.
For all 10 centres, a total of 32 566 prescriptions of PIMs were dispensed before the intervention period, which decreased to 27 041 after the intervention. A decrease of 22.2% in the intervention group (from 19 796 to 15 400) compared to a decrease of 8.8% in the comparison group (from 12 770 to 11 641) ( Table 2 ).
The average number of prescriptions per patient remained unchanged in the intervention group (7.48-7.48), while it increased in the comparison group after the intervention period (7.64-8.81); however, this difference was not significant.
The overall most common group of PIMs before the intervention was anticholinergics, followed by antipsychotics and NSAIDs. This did not change after the intervention. In the intervention group, the largest decrease was seen for propiomazine and tramadol. In the comparison group, long-acting benzodiazepines, NSAIDs and tramadol decreased while antipsychotics and propiomazine increased (Table 2) . Regarding number of patients receiving PIMs, this decreased for all groups of PIMs, except for antipsychotics in the comparison group (Table 3) . For all centres, the most common PIMs before the intervention were tramadol, diclofenac, propiomazine and naproxen. After intervention, this changed slightly to tramadol, naproxen, diclofenac and hydroxyzine. Tramadol and propiomazine showed major reductions as mentioned above, while hydroxyzine decreased only by 1.5% for example.
For all 10 primary care centres, the number of patients with multi-dose drug dispensing increased from 13.8% to 16.4%, but the group with both kinds of dispensing decreased after the intervention. There was a significant difference between the two groups regarding prescriptions of PIMs (Table 4 ). The most common PIM groups in patients with ordinary prescriptions were NSAIDs, anticholinergics and tramadol. This segmentation remained after the intervention even though the number of patients receiving PIMs decreased. For patients with multi-dose drug dispensing, the most common drug group was antipsychotics, anticholinergics and long-acting benzodiazepines. After intervention, the segmentation remained the same, including a 13.6% increase in prescriptions of antipsychotics.
For four of the five primary care centres in the intervention group, fewer patients received PIMs and the mean DDD/patient was lower after the intervention. Of the centres in the control group, only one had more patients on PIMs after, but three demonstrated an increase in mean DDD/patient. In total, the intervention group showed a significant decrease in mean DDD/patient, whereas the control group did not (Table 5) .
For the total study population, no significant differences between men and women in mean DDD/patient were seen. In general, the age group 65-79 years received a higher mean DDD/patients than did the 80+ group, and this was significant (P < 0.05) for long-acting benzodiazepines, anticholinergics, tramadol and antipsychotics before the intervention. After intervention, the difference remained but was significant only for long-acting benzodiazepines and antipsychotics.
Discussion
In the intervention group, there was a significant decrease of the prescription of PIMs in primary care, but not in the control group. This indicates that the SÄKLÄK intervention is an effective way to reduce potential DRPs.
We noted that the intervention led to a significant lower mean DDD/patient in the intervention group, whereas the comparison group showed a much smaller change. According to national Swedish data, there has been a decrease in use of PIMs in Sweden of 44% from 2005 to 2014 (8). This could be explained by focused efforts by the Swedish county councils and a national improvement strategy. However, the studied intervention led to a difference between intervention and comparison centres, indicating something beyond the national improvement strategy.
The SÄKLÄK intervention was a multiprofessional intervention model created to improve medication safety for elderly patients in primary care and consisted of self-assessment followed by peer review, feedback and a written agreement for change. Earlier studies have shown that educational outreach visits to GPs can affect prescribing patterns regarding PIMs (16) . In a register study by Hovstadius et al. (17) , all PIM groups except anticholinergics decreased, and in our study, anticholinergics showed the smallest decrease. This could be attributed to the fact that there are few or no alternative therapies available for anticholinergics compared to the other groups.
There is a difficulty comparing studies since the definitions of PIMs and what is being measured (prescriptions, individuals, DDD) as well as the setting (assisted living or patients living at home) differ. We included long-acting benzodiazepines, anticholinergics, tramadol, propiomazine, antipsychotics and NSAIDs. Regarding NSAIDs, the real use might be higher than shown here, since they also are available OTC. We did not have data on OTC use but since the intervention was not only targeting doctors but also for example nurses and pharmacists, it might potentially have affected the use of OTC drugs (for example NSAIDs) as well. This however remains to be concluded.
We know from previous evaluations of the intervention method that the multiprofessional approach was perceived as something very positive (14) , and this could be the part of the intervention that makes the difference in PIMs between the groups (i.e. reaching broader than previous efforts). The self-assessment helped the centres to identify areas of improvement, and prescription of PIMs might be one of these, and the agreement for change set a timetable for when to do it. The impact of reviewers could be on how to do it. Although women constitute 54.2% of the Swedish 65+ population according to Statistics Sweden, they receive around 63% of the PIMs in this study before the intervention. It is known that women use more medications than men, and this seems to be true for PIMs as well. This has also been shown in other studies (11, 18) .
We saw a difference in mean DDD/patient for some PIMs between the two age groups, indicating that the older patients are getting lower doses or shorter treatments, which is as it should be. Other studies have shown no clear evidence, with both a higher risk for getting PIMs prescribed with older age (10, 17) and more PIMs to younger nursing home residents than to older ones (19) .
The differences we saw in prescription of PIMs between ordinary prescriptions and multi-dose drug dispensing, antipsychotics are more common in the latter group for example, are likely due to the fact that patients with multi-dose dispensed medications are sicker and more often nursing home residents. There are also studies showing that these patients have fewer changes of their therapy than patients with ordinary prescriptions (20) , which could lead to longer periods of treatment with PIMs.
One strength of this study was the representation of participating primary care centres from different parts of Sweden and from both urban and rural areas. Another strength is the data from the Swedish Prescribed Drug Register that provides complete national data on the number of individuals exposed to dispensed drugs in the Swedish population. In contrast to some other countries, all prescription drugs, irrespective of reimbursement status, are included in the register.
This study has some important limitations. It was a small pilot study with 10 primary care centres with the aim to evaluate if a method developed in hospital care is useful in primary care. This limits the opportunities to directly apply these results to primary care centres in Sweden or other countries.
Due to the limitations of the data, we were unable to analyse whether the intervention led to a decrease in number of PIMs per patient for example, but the study shows an overall decrease of PIMs. However, it is not certain that this is due to the intervention. The Drug Register does not provide information on diagnosis or indication for treatment. Therefore, we must assume there may be a rationale behind some of the 'inappropriate' treatments found, even though these PIMs are classified as inappropriate on a group level.
Further studies with more centres are needed to establish the effects of the SÄKLÄK project on prescription of PIMs, as well as studies of other interventions to optimize medication treatment of older patients in primary care.
Conclusion
Our study shows some positive effects on prescription of PIMs. This evaluation indicates this is a feasible method for improvement of medication use in primary care and the method should be tested on a larger scale.
